We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000158:SSEShijiazhuang ChangShan BeiMing Technology Co.,Ltd Analysis

Data as of 2026-07-16 - not real-time

CN¥12.81

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at 12.81 CNY, which sits below its 20‑day SMA of 13.21, its 50‑day SMA of 14.86 and far under the 200‑day SMA of 19.42, underscoring a clear bearish trend. Technical indicators show a modestly oversold RSI at 39 and a bullish MACD histogram, suggesting a potential short‑term bounce from the support level around 12.34. However, the fundamentals are starkly weak: a trailing PE of 640×, negative operating margin, ROE under 1%, and a debt‑to‑equity ratio exceeding 110% point to severe profitability and balance‑sheet pressures. The DCF‑derived fair value of roughly 3.65 CNY implies the market price is dramatically overvalued, and the meager dividend yield of 0.21% is not sustainable given the zero payout ratio. Volatility is high at nearly 49% over the past month, while beta is low, indicating price swings are driven more by company‑specific risk than market movements. In sum, the stock faces a convergence of technical softness, inflated valuation, and structural financial weakness, making any upside highly speculative.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering near technical support at 12.34 CNY
  • Bullish MACD crossover suggests limited near‑term upside
  • Elevated 30‑day volatility increases price swing risk

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Market price far exceeds DCF fair value of ~3.65 CNY
  • High leverage with debt‑to‑equity over 110% and negative operating margins
  • Weak profitability metrics (ROE, ROA) limit earnings growth

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Structural lack of sustainable earnings and cash conversion
  • Unsustainable dividend policy and zero payout ratio
  • Persistent overvaluation and exposure to Chinese consumer‑cyclical slowdown

Key Metrics & Analysis

Financial Health

Revenue Growth6.20%
Profit Margin0.41%
P/E Ratio640.5
ROE0.53%
ROA0.60%
Debt/Equity113.05
P/B Ratio3.9
Op. Cash FlowCN¥109.9M
Free Cash FlowCN¥614.9M

Technical Analysis

TrendBearish
RSI39.1
SupportCN¥12.34
ResistanceCN¥15.01
MA 20CN¥13.21
MA 50CN¥14.86
MA 200CN¥19.42
MACDBullish
VolumeStable
Fear & Greed Index93.45

Valuation

Fair ValueCN¥3.65
GradeOvervalued
TypeValue
Dividend Yield0.21%

Risk Assessment

Beta0.25
Volatility48.64%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.